- CATB +27% on announcing additional favorable results across multiple functional assessments in the MoveDMD trial.
- CANF +23% on announcing that Barzilai Medical Center's Institutional Review Board has approved the Phase III ACRobat trial protocol and patient enrollment for the study at the 627-bed hospital in Ashkelon, Israel.
- CTIC +16% on agreeing to expand their existing license and development collaboration agreement for PIXUVRI.
- UIS +14%.
- CAPR +12% on announcing positive top-line results from a safety and exploratory efficacy analysis of six-month data from the randomized 12-month Phase I/II HOPE Clinical Trial of CAP-1002.
- LLNW +11%.
- APFH +9% on Q1 earnings beat.
- QURE +9%.
- STRP +8% on an unsolicited offer from a multi-national telecommunications company to acquire 100% of the issued and outstanding shares of Straight Path for $104.64 per share.
- SVU +8% on Q1 earnings beat.
- MDR +7% on Q1 earnings beat.
- IDRA +6%.
- CAT +6% on Q1 earnings beat
- AKS +5% on Q1 earnings beat.
- TGTX +5%.
- Now read: McDermott International, Inc. 2017 Q1 - Results - Earnings Call Slides
Original article